Granados CE et al: Drugs for treating giardiasis. Cochrane Database Syst Rev 2012;(12):CD007787.
Leitsch D: Drug resistance in the microaerophilic parasite Giardia lamblia. Curr Trop Med Rep 2015;2:128.
Marcos LA, Gotuzzo E: Intestinal protozoan infections in the immunocompromised host. Curr Opin Infect Dis 2013;26:295.
Pierce KK et al: Update on human infections caused by intestinal protozoa. Curr Opin Gastroenterol 2009;25:12.
Pritt BS, Clark DG: Amebiasis. Mayo Clin Proc 2008;83:1154.
Ross AG et al: Enteropathogens and chronic illness in returning travelers. N Engl J Med 2013;368:1817.
Rossignol JF: Cryptosporidium and Giardia: Treatment options and prospects for new drugs. Exp Parasitol 2010;124:45.
Wright SG: Protozoan infections of the gastrointestinal tract. Infect Dis Clin North Am 2012;26:323.
Aronson NE et al: A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection. PLoS Negl Trop Dis 2010;4:e628.
Ben Salah A et al: Topical paromomycin with or without gentamicin for cutaneous leishmaniasis. N Engl J Med 2013;368:524.
Bern C: Chagas’ disease. N Engl J Med 2015;373:456.
Bhattacharya SK et al: Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. J Infect Dis 2007;196:591.
Bisser S et al: Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness. J Infect Dis 2007;195:322.
Brun R, Blum J: Human African trypanosomiasis. Infect Dis Clin North Am 2012;26:261.
Brun R et al: Human African trypanosomiasis. Lancet 2010;375:148.
Burza S et al: Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, India. PLoS Negl Trop Dis 2014;8:e2603.
Goto H, Lauletta Lindoso JA: Cutaneous and mucocutaneous leishmaniasis. Infect Dis Clin North Am 2012;26:293.
Hailu A et al: Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: A multicentre, open-label, randomized trial. PLoS Negl Trop Dis 2010;4:e709.
Jackson Y et al: Tolerance and safety of nifurtimox in patients with chronic Chagas disease. Clin Infect Dis 2010;51:e69.
Kennedy PG: Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol 2013;12:186.
Lescure FX et al: Chagas disease: Changes in knowledge and management. Lancet Infect Dis 2010;10:556.